dihydroergotamine has been researched along with ergonovine in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (81.48) | 18.7374 |
1990's | 1 (3.70) | 18.2507 |
2000's | 4 (14.81) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K | 1 |
Kerekes, A; Policova, Z; Sirek, A; Sirek, OV | 1 |
Angus-Leppan, H; Boers, PM; Lambert, GA; Lowy, AJ; Zagami, AS | 1 |
Sakanashi, M; Yonemura, KI | 1 |
Johnson, ZB; Moubarak, AS; Rosenkrans, CF | 1 |
SIMKOVA, M | 1 |
CAMINITI, R; CORELLI, D | 1 |
HORTON, BT; PETERS, GA | 1 |
HERSCHBERG, AD | 1 |
LEIBETSEDER, FJ | 1 |
JACOB, O | 1 |
VODOPIVEC, M | 1 |
CALDWELL, WG | 1 |
POLLOCK, LA | 2 |
GAROBY, JP; MAIRE, R; REDER, J | 1 |
DE BOER, J; VAN DONGEN, K | 1 |
MOHME, E | 1 |
Callaway, TR; Edrington, TS; Looper, ML; Moubarak, AS; Rosenkrans, CF | 1 |
ABREU, BE; LIDDLE, GW | 1 |
KOPPANYI, T | 1 |
DANNENBERG, T | 1 |
GOTTHELF, EJ | 1 |
FRIEDMAN, DA; FRIEDMAN, MD | 1 |
ORTH, OS | 1 |
27 other study(ies) available for dihydroergotamine and ergonovine
Article | Year |
---|---|
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine | 2002 |
Effect of ergot alkaloids on sulfonylurea-stimulated insulin secretion in dogs.
Topics: Animals; Blood Glucose; Dihydroergotamine; Dihydroergotoxine; Dogs; Ergonovine; Ergot Alkaloids; Ergotamine; Female; Injections, Intravenous; Insulin; Insulin Secretion; Male; Secretory Rate; Sulfonylurea Compounds | 1977 |
The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids.
Topics: Action Potentials; Animals; Cats; Cranial Sinuses; Dihydroergotamine; Electric Stimulation; Ergonovine; Ergotamine; Evoked Potentials; Neural Pathways; Spinal Cord | 1992 |
On the mode of action of ergometrine in the isolated dog coronary artery.
Topics: Animals; Arteries; Coronary Vessels; Dihydroergotamine; Dogs; Dose-Response Relationship, Drug; Ergonovine; In Vitro Techniques; Methysergide; Phenoxybenzamine; Phentolamine; Receptors, Serotonin; Serotonin; Vasoconstriction | 1980 |
Modulation of cytochrome P450 metabolism by ergonovine and dihydroergotamine.
Topics: Animals; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dihydroergotamine; Dose-Response Relationship, Drug; Ergonovine; Ergot Alkaloids; Infusions, Parenteral; Isomerism; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley | 2003 |
[Therapy of herpetic diseases of the cornea with dihydroergotamine and gynergen].
Topics: Cornea; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Humans | 1950 |
[Graphic study on the motility of the stomach in hyperthyroidism; action of dihydroergotamine].
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Hyperthyroidism; Stomach | 1950 |
Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine.
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Headache | 1950 |
[Treatment of migraine by dihydroergotamine].
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders | 1950 |
[Changes effected by adrenalin and dihydroergotamine during the first phase of blood coagulation].
Topics: Blood Coagulation; Dihydroergotamine; Epinephrine; Ergonovine; Ergot Alkaloids | 1951 |
[Experiences with dihydroergotamine in otorhinology].
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Otolaryngology | 1951 |
[Effect of dihydroergotamine and hydergin on urinary excretion of potassium].
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Potassium | 1951 |
[First experiences with dihydroergotamine in labor].
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Female; Humans; Labor, Obstetric; Pregnancy; Work | 1951 |
The treatment of postlumbar puncture headache with DHE-45 (dihydroergotamine).
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Headache; Post-Dural Puncture Headache; Punctures | 1950 |
Further experience with dihydroergotamine methanesulfonate in the treatment of migraine; with a note on the use of cafergone.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders | 1949 |
[Effects of dihydroergotamine in 2 cases of duodenal ulcers].
Topics: Claviceps; Dihydroergotamine; Duodenal Ulcer; Ergonovine; Ergot Alkaloids; Humans; Peptic Ulcer | 1950 |
Experiments with dihydroergotamine.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids | 1948 |
Effect of dihydroergotamine on the oxygen consumption; experiments on cats.
Topics: Animals; Cats; Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Oxygen; Oxygen Consumption | 1949 |
Effects of the ergot alkaloids dihydroergotamine, ergonovine, and ergotamine on growth of Escherichia coli O157:H7 in vitro.
Topics: Analysis of Variance; Animals; Cattle; Cattle Diseases; Colony Count, Microbial; Dihydroergotamine; Ergonovine; Ergotamine; Escherichia coli Infections; Escherichia coli O157; Festuca; Food Microbiology; Regression Analysis; Rumen | 2008 |
Effects of amphetamine, dihydroergotamine, and methadon on human cerebral blood flow and oxygen uptake.
Topics: Amphetamine; Amphetamines; Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Methadone; Oxygen | 1948 |
Dihydroergotamine (D.H.E. 45), a new and effective drug in the treatment of migraine.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Migraine Disorders | 1946 |
A new artificial ergot derivative, dehydroergotamine (DHE45).
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans | 1946 |
Comparison of dihydroergotamine, ergotamine and other agents in the treatment of migraine.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Migraine Disorders | 1946 |
D.H.E. 45 (dihydroergotamine) a new drug in the treatment of migraine.
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Migraine Disorders | 1946 |
Dihydroergotamine in the treatment of migraine; preliminary clinical observations.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders | 1945 |
Studies of the sympathicolytic drug dihydroxyergotamine, D.H.E.45.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Nervous System; Sympathetic Nervous System | 1946 |